Trials / Not Yet Recruiting
Not Yet RecruitingNCT07516899
Mass Balance Study of [14C] LPM3770164 in Healthy Participants
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (estimated)
- Sponsor
- Luye Pharma Group Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a phase 1, single-center, single-dose, open-label mass-balance study to evaluate radioactive recovery rate, radioactive PK characteristics, metabolite identification, and to observe the safety in healthy male subjects of \[14C\] LPM3770164.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C] LPM3770164 | The subjects are required to take 20 mg/150 µCi \[14C\] LPM3770164 tablet (s) in the fasted state with a total of approximately 240 mL of water to ensure completion within 5 minutes |
Timeline
- Start date
- 2026-04-30
- Primary completion
- 2026-06-30
- Completion
- 2026-07-30
- First posted
- 2026-04-08
- Last updated
- 2026-04-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07516899. Inclusion in this directory is not an endorsement.